U-62066 (SPIRADOLINE MESYLATE) K-OPIOID AGONIST
U-62066 (SPIRADOLINE MESYLATE) K-OPIOID AGONIST Basic information
- Product Name:
- U-62066 (SPIRADOLINE MESYLATE) K-OPIOID AGONIST
- Synonyms:
-
- U-62066 (SPIRADOLINE MESYLATE) K-OPIOID AGONIST
- Spiradoline
- (±)-(5α,7α,8β)-3,4-dichloro-n-methyl-n-[7-(1-pyrrolidinyl)-1-oxaspiro[4.5]dec-8-yl]benzeneacetamide mesylate salt
- Spiradoline mesylate salt, (±)-(5α,7α,8β)-3,4-Dichloro-N-methyl-N-[7-(1-pyrrolidinyl)-1-oxaspiro[4.5]dec-8-yl]benzeneacetamide mesylate salt
- Benzeneacetamide, 3,4-dichloro-N-methyl-N-(7-(1-pyrrolidinyl)-1-oxaspiro(4,5)dec-8-yl)-, (5alpha,7alpha,8beta)-(+-)-
- Espiradolina
- Espiradolina [spanish]
- Spiradolinum
- CAS:
- 87151-85-7
- MF:
- C22H30Cl2N2O2
- MW:
- 425.39
- Mol File:
- 87151-85-7.mol
U-62066 (SPIRADOLINE MESYLATE) K-OPIOID AGONIST Chemical Properties
- storage temp.
- 2-8°C
- solubility
- H2O: soluble14mg/mL
- form
- solid
- color
- white
- Water Solubility
- H2O: 14mg/mL
methanol: insoluble
U-62066 (SPIRADOLINE MESYLATE) K-OPIOID AGONIST Usage And Synthesis
Uses
Analgesic.
Uses
U 62066 is a selective κ-opioid agonist. It exhibits analgesic, diuretic and antitussive properties.
Biological Activity
U-62066, also known as spiradoline, is a highly selective K opioid receptor agonist. It exhibits analgesic and diuretic effects. Antitussive property of U-62066 is observed in rats.
in vivo
Spiradoline (U-62066; 0.1-0.4 mg/kg; subcutaneous injection; once; Sprague-Dawley rats) treatment dose-dependently reduces social behaviors in non-stressed adults, producing social avoidance at the highest dose tested, while younger animals displays reduced sensitivity to this socially suppressing effect of Spiradoline. In stressed animals, the socially suppressing effects of the Spiradoline are blunted at all ages, with juveniles and adolescents exhibiting increased social preference in response to certain doses of U-62066[1].
| Animal Model: | Juvenile, adolescent and adult Sprague-Dawley male and female rats exposured to repeated restraint[1] |
| Dosage: | 0.1 mg/kg, 0.2 mg/kg, 0.3 mg/kg, and 0.4?mg/kg |
| Administration: | Subcutaneous injection; once |
| Result: | Dose-dependently reduced social behaviors in non-stressed adults, producing social avoidance at the highest dose tested. |
U-62066 (SPIRADOLINE MESYLATE) K-OPIOID AGONISTSupplier
- Tel
- 021-021-59178156 15300768757
- 359382369@qq.com
- Tel
- 021-34675735 19147740836
- 1986399151@qq.com
- Tel
- 025-85560043 15850508050
- cindy.huang@synzest.com